Morningstar Investor users sign in here.

Company Profile

  • Business description

    Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

  • Contact

    47 Hulfish Street
    Princeton NJ 08542
    USA

    T: +1 609 662-2000

    E: ir@amicusrx.com

    https://www.amicusrx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    517

Stocks News & Analysis

stocks

Surge in ASX share may be overblown

After an acquisition bid for Premier’s Apparel Brands business Myer shares soared but the combination may exacerbate existing risk to the business.  
stocks

3 cheap Wide Moat stocks in a divided industry

All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far. 
stocks

3 industries to focus on for high quality investments

Some industries are moaty by nature. One that is deeply out of favour offers a prime example.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,975.10 64.80 -0.81%
CAC 40 7,706.89 78.32 1.03%
DAX 40 18,325.58 162.06 0.89%
Dow JONES (US) 39,411.21 260.88 0.67%
FTSE 100 8,281.55 43.83 0.53%
HKSE 18,027.71 0.81 -0.00%
NASDAQ 17,496.82 192.54 -1.09%
Nikkei 225 38,804.65 208.18 0.54%
NZX 50 Index 11,590.32 37.54 -0.32%
S&P 500 5,447.87 16.75 -0.31%
S&P/ASX 200 7,733.70 62.30 -0.80%
SSE Composite Index 2,963.10 35.04 -1.17%

Market Movers

Name
Last price
Change
% Change
Imugene Ltd IMU 0.06 0.00 -6.78%
Peninsula Energy Ltd PEN 0.10 0.02 -13.04%
Red 5 Ltd RED 0.41 0.01 -2.38%
Sayona Mining Ltd SYA 0.03 0.00 -2.86%
Cettire Ltd CTT 1.14 1.11 -49.33%
Liontown Resources Ltd LTR 0.91 0.03 -2.67%
Core Lithium Ltd CXO 0.08 0.00 -4.82%
Botanix Pharmaceuticals Ltd BOT 0.38 0.02 4.17%
Telstra Group Ltd TLS 3.62 0.04 -1.09%
Droneshield Ltd DRO 1.53 0.12 -7.01%